|
⚲
|
| Keyboard |
| Sanders Charles A
✚
|
|
|---|---|
| CIK # | 0001022936 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001022936] | |
| 4 | [0001022936] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sanders Charles A | |
| Biocryst Pharmaceuticals Inc | |
| Liposcience Inc | |
| Albireo Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2016-02-29 | Grant | 4,396 | $1.99 | 8,748 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2015-11-30 | Grant | 824 | $10.61 | 8,743 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2015-08-31 | Grant | 751 | $11.64 | 8,742 |
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2015-05-20 | Grant | 15,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2014-05-02 | Grant | 15,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2013-05-31 | Grant | 15,000 | $0.00 | |
|
Liposcience Inc LPDX
Common Stock
|
2013-01-30 | Conversion | 1,114 | ||
|
Liposcience Inc LPDX
Series E Convertible Preferred Stock · derivative
|
2013-01-30 | Conversion | 2,298 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2012-05-23 | Grant | 15,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2012-03-13 | Buy | 2,000 | $5.22 | 10,440 |
|
Albireo Pharma Inc BIOD
Stock Option (right to buy) · derivative
|
2012-03-08 | Grant | 20,000 | $0.00 |